These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26472442)

  • 1. Preparation of a Cyclic RGD: Modified Liposomal SiRNA Formulation for Use in Active Targeting to Tumor and Tumor Endothelial Cells.
    Sakurai Y; Hada T; Harashima H
    Methods Mol Biol; 2016; 1364():63-9. PubMed ID: 26472442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
    J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption.
    Yamamoto S; Sakurai Y; Harashima H
    Int J Pharm; 2018 Jan; 536(1):42-49. PubMed ID: 29126905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature.
    Sakurai Y; Kajimoto K; Harashima H
    Biomater Sci; 2015 Sep; 3(9):1253-65. PubMed ID: 26261854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles.
    Vader P; Crielaard BJ; van Dommelen SM; van der Meel R; Storm G; Schiffelers RM
    J Control Release; 2012 Jun; 160(2):211-6. PubMed ID: 21983283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of a labeled RGD-lipid, its incorporation into liposomal nanoparticles, and their trafficking in cultured endothelial cells.
    Cressman S; Dobson I; Lee JB; Tam YY; Cullis PR
    Bioconjug Chem; 2009 Jul; 20(7):1404-11. PubMed ID: 19534457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cRGD grafted liposomes containing inorganic nano-precipitate complexed siRNA for intracellular delivery in cancer cells.
    Khatri N; Baradia D; Vhora I; Rathi M; Misra A
    J Control Release; 2014 May; 182():45-57. PubMed ID: 24631861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells.
    Hada T; Sakurai Y; Harashima H
    Pharmaceutics; 2015 Sep; 7(3):320-33. PubMed ID: 26389942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.
    Yang ZZ; Li JQ; Wang ZZ; Dong DW; Qi XR
    Biomaterials; 2014 Jun; 35(19):5226-39. PubMed ID: 24695093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An apolipoprotein E modified liposomal nanoparticle: ligand dependent efficiency as a siRNA delivery carrier for mouse-derived brain endothelial cells.
    Tamaru M; Akita H; Kajimoto K; Sato Y; Hatakeyama H; Harashima H
    Int J Pharm; 2014 Apr; 465(1-2):77-82. PubMed ID: 24530390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of siRNA Delivery Targeting the Tumor Microenvironment with a New Functional Device].
    Sakurai Y
    Yakugaku Zasshi; 2019; 139(11):1357-1363. PubMed ID: 31685731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand density at the surface of a nanoparticle and different uptake mechanism: two important factors for successful siRNA delivery to liver endothelial cells.
    Akhter A; Hayashi Y; Sakurai Y; Ohga N; Hida K; Harashima H
    Int J Pharm; 2014 Nov; 475(1-2):227-37. PubMed ID: 25169077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA.
    Sakurai Y; Hatakeyama H; Sato Y; Akita H; Takayama K; Kobayashi S; Futaki S; Harashima H
    Biomaterials; 2011 Aug; 32(24):5733-42. PubMed ID: 21605898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of a novel adapter lipid derivative for preparation of cyclic peptide-modified PEGylated liposomes: Application of cyclic RGD peptide.
    Kato N; Sato T; Fuchigami Y; Suga T; Geng L; Tsurumaru M; Hagimori M; Mukai H; Kawakami S
    Eur J Pharm Sci; 2022 Sep; 176():106239. PubMed ID: 35714942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.
    Sato Y; Hatakeyama H; Sakurai Y; Hyodo M; Akita H; Harashima H
    J Control Release; 2012 Nov; 163(3):267-76. PubMed ID: 23000694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic liposome decorated with cyclic RGD peptide for targeted delivery of anti-STAT3 siRNA to melanoma cancer cells.
    Khabazian E; Vakhshiteh F; Norouzi P; Fatahi Y; Dinarvand R; Atyabi F
    J Drug Target; 2022 Jun; 30(5):522-533. PubMed ID: 34482780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic peptide-based nanostructures as efficient siRNA carriers.
    Panigrahi B; Singh RK; Mishra S; Mandal D
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S763-S773. PubMed ID: 30311806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma.
    Waite CL; Roth CM
    Bioconjug Chem; 2009 Oct; 20(10):1908-16. PubMed ID: 19775120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-specific siRNA delivery by peptides and antibodies.
    Lee SK; Siefert A; Beloor J; Fahmy TM; Kumar P
    Methods Enzymol; 2012; 502():91-122. PubMed ID: 22208983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in an active and passive targeting to tumor and adipose tissues.
    Sakurai Y; Kajimoto K; Hatakeyama H; Harashima H
    Expert Opin Drug Deliv; 2015 Jan; 12(1):41-52. PubMed ID: 25376864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.